奧聯電子(300585.SZ):奧聯投資減持期屆滿 累計減持161.79萬股
格隆匯11月18日丨奧聯電子(300585.SZ)公佈,公司於近日收到奧聯投資出具的關於股份減持計劃期限屆滿及實施進展的告知函。截至2019年11月15日,奧聯投資前述減持計劃期限已屆滿,減持計劃實施完畢。在該減持計劃期間,奧聯投資計劃減持公司股份170.4萬股(佔公司總股本的1.0650%),實際通過深圳證券交易所以集中競價交易方式減持161.79萬股(佔公司總股本的1.0112%)。
此次減持後,奧聯投資持股比例由3.2400%降至2.2288%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.